Kamlesh K. Khunti
Elite in Type 2 Diabetes (T2D)

Kamlesh K. Khunti

Gwendolen Road, 
Leicester, ENG, GB 
Elite in Type 2 Diabetes (T2D)
Gwendolen Road, 
Leicester, ENG, GB 
OverviewLocationsClinical Research

Overview

Kamlesh Khunti practices in Leicester, United Kingdom. Khunti is rated as an Elite expert by MediFind in the treatment of Type 2 Diabetes (T2D). Their top areas of expertise are Type 2 Diabetes (T2D), Low Blood Sugar, Long Haul COVID, COVID-19, and Percutaneous Coronary Intervention (PCI).

Their clinical research consists of co-authoring 1236 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 604 articles and participated in 2 clinical trials in the study of Type 2 Diabetes (T2D).

Locations

Gwendolen Road, Leicester, ENG, United Kingdom
Other Locations
Leicester General Hospital Gwendolen Rd, Leicester, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Comparison of Optimal Hypertension Regimens (Part of the Ancestry Informative Markers in Hypertension (AIMHY) Programme - AIMHY-INFORM)
Comparison of Optimal Hypertension Regimens (Part of the Ancestry Informative Markers in Hypertension (AIMHY) Programme - AIMHY-INFORM)
Enrollment Status: Completed
Publish Date: September 05, 2025
Intervention Type: Drug
Study Drugs: Amlodipine, Lisinopril, Amiloride, Chlortalidone
Study Phase: Phase 4
A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients (DECIDE Study)
A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients (DECIDE Study)
Enrollment Status: Active_not_recruiting
Publish Date: December 16, 2024
Intervention Type: Drug
Study Drugs: Dapagliflozin, Standard of Care
Study Phase: Phase 4
Impact of Liraglutide on Cardiac Function and Structure in Young Adults With Type 2 Diabetes: an Open-label, Randomised Active-comparator Trial
Impact of Liraglutide on Cardiac Function and Structure in Young Adults With Type 2 Diabetes: an Open-label, Randomised Active-comparator Trial
Enrollment Status: Completed
Publish Date: January 30, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

1235 Total Publications

Understanding structured medication reviews delivered by clinical pharmacists in primary care in England: a national cross-sectional survey.
Understanding structured medication reviews delivered by clinical pharmacists in primary care in England: a national cross-sectional survey.
Journal: BMJ open
Published: October 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Khunti's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 10 Advanced Conditions
View All 49 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile